EKF Diagnostics (LON:EKF) Stock Breaks Below 200 Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF) passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of GBX 25.50 and traded as low as GBX 24.16. EKF Diagnostics shares last traded at GBX 24.70, with a volume of 55,401 shares changing hands.

EKF Diagnostics Price Performance

The business has a 50-day moving average of GBX 25.08 and a two-hundred day moving average of GBX 25.52. The company has a current ratio of 4.72, a quick ratio of 1.77 and a debt-to-equity ratio of 2.09. The firm has a market cap of £104.00 million, a P/E ratio of 41.90 and a beta of 0.50.

EKF Diagnostics (LON:EKF) last posted its earnings results on Tuesday, September 15th. The company reported GBX 0.54 EPS for the quarter. EKF Diagnostics had a return on equity of 3.58% and a net margin of 4.86%. On average, sell-side analysts anticipate that EKF Diagnostics Holdings plc will post 2.30 earnings per share for the current fiscal year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.